Overview
Raffaele Spadano practices practicing medicine in Pescara, Italy.
His clinical expertise encompasses Myeloproliferative Neoplasms (MPN) and Chronic Myelogenous Leukemia (CML).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Raffaele Spadano
Is Raffaele Spadano a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Raffaele Spadano is classified as an Experienced expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Raffaele Spadano participate in research or clinical trials?
Yes. Raffaele Spadano has published 8 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Raffaele Spadano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Myelogenous Leukemia (CML)Mr. Spadano isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Myeloproliferative Neoplasms (MPN)Mr. Spadano isExperienced. Learn about Myeloproliferative Neoplasms (MPN).